XNAS:F:F-Xtrackers NASDAQ 100 UCITS ETF 1C EUR (EUR)

ETF | Others |

Last Closing

USD 48.39

Change

+0.65 (+1.35)%

Market Cap

USD 0.67B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.07 (+0.14%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

+4.82 (+0.78%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.09 (+0.17%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.12 (+0.76%)

USD 63.18B
VUSA:F Vanguard Funds Public Limited ..

+1.09 (+0.99%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.09 (+0.98%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

-0.06 (-0.73%)

USD 43.12B
0ZC:F Zscaler Inc

+2.94 (+1.63%)

USD 37.92B

ETFs Containing XNAS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.43% 57% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.43% 56% F 54% F
Trailing 12 Months  
Capital Gain 32.52% 90% A- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.52% 87% B+ 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 19.21% 93% A 80% B-
Dividend Return 19.21% 91% A- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.35% 30% F 74% C
Risk Adjusted Return 110.73% 96% N/A 96% N/A
Market Capitalization 0.67B 69% C- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.